Cardiovascular safety of oncologic agents: a double-edged sword even in the era of targeted therapies - Part 2. [electronic resource]
Producer: 20181019Description: 893-915 p. digitalISSN:- 1744-764X
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.